Defibrotide News
Defibrotide currently has 0 news articles, with 20 predicted indications.
This page combines the AI-predicted indications for Defibrotide with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
- Original indication: Defitelio is indicated for the treatment of severe hepatic veno-occlusive disease (VOD) also known as sinusoidal obstructive syndrome (SOS) in haematopoietic stem-cell transplantation (HSCT) therapy....
- Evidence level: L5
- Predicted indications (20):
- pseudo-von Willebrand disease (99.9%)
- primary release disorder of platelets (99.9%)
- Glanzmann thrombasthenia (99.9%)
- thrombotic thrombocytopenic purpura (99.7%)
- Scott syndrome (99.7%)
- bleeding diathesis due to a collagen receptor defect (99.4%)
- hemorrhagic disorder due to a constitutional thrombocytopenia (99.4%)
- congenital factor V deficiency (99.3%)
- fetal and neonatal alloimmune thrombocytopenia (99.2%)
- thrombocytopenic purpura (99.2%)
- inherited thrombophilia (99.2%)
- hepatic infarction (99.1%)
- peliosis hepatis (99.0%)
- familial apolipoprotein C-II deficiency (98.8%)
- syndrome with combined immunodeficiency (98.8%)
- platelet-type bleeding disorder (98.7%)
- Ehlers-Danlos syndrome, fibronectinemic type (98.7%)
- hepatic veno-occlusive disease (98.7%)
- flood factor deficiency (98.6%)
- methylcobalamin deficiency type cblG (98.2%)
Related News (0)
No related news yet. When news mentions this drug, it will be collected and shown here automatically.
Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.